Botox and Juvederm Maker to Purchase SkinMedica
Allergan, a top manufacturer for several anti-aging treatments, has decided to purchase SkinMedica’s line of topical cosmetic skin care products for $350 million. Allergan Chief Executive David E. I. Pyott says that SkinMedica will complement Allergan’s already long list of facial wrinkle treatments including Botox® Cosmetic and Juvederm®. Pyott also added that the acquisition “will enable
